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Background/aim: The aim of this study is to present the results of modified combined decongestive therapy (CDT) in patients with
lower extremity lymphedema (LEL).
Materials and methods: We retrospectively reviewed 95 patients aged 55.84 ± 15.70 years who had been diagnosed with LEL between
May 2015 and May 2017. The patients were treated for 4 weeks with modified CDT, including self-manual lymphatic drainage, selfbandaging, decongestive exercises, and skin care.
Results: The mean reduction amounts of edema volume before and after treatment were 296.05, 784.92, and 1038.50 mL for stages 1,
2, and 3 respectively (P = 0.001). There were significant differences between the values before and after treatment in excess extremity
volume (EEV) at all stages (P = 0.001). The EEV percentages of the secondary LEL patients were higher than those of the primary LEL
patients (P = 0.04). There was no correlation between BMI and treatment response in terms of EEV percentages (r = –0.99; P = 0.36).
Conclusion: Our results revealed that home-based modified CDT is more effective in reducing extremity edema volume in secondary
LEL than primary LEL. It should be an available method for self-management of LEL at all stages.
Key words: Lower extremity lymphedema, self-management, complex decongestive therapy

1. Introduction
Lymphedema is a chronic, progressive condition that
can affect a significant number of people and have effects
on patients’ physical and physicosocial health [1]. A
substantial number of patients suffer from this irreversible,
permanent, and debilitating disease. Without proper
management, lymphedema may progress, resulting in the
proliferation of fibrotic tissue, an increase in the size of
the affected extremity, and increased risk for wounds and
infections [2,3]. Lower extremity lymphedema (LEL) may
occur as a primary (dysfunction of the lymphatic system)
or secondary (e.g., removal of lymph nodes, radiation
therapy, trauma) condition [4,5].
LEL management is life-long, and it may include
mainly conservative, sometimes medical, and rarely
surgical treatments [6–9]. The gold standard treatment
of lymphedema is combined decongestive therapy (CDT)
[10,11]. CDT consists of a two-step program carried out
by a professional team, including specifically trained
lymphologists and physiotherapists. The first step is
known as Phase 1, which primarily includes skin care,

manual lymphatic drainage (MLD), use of multilayered
compression bandages, and exercises. The second step,
called Phase 2, is primarily seen as a maintenance stage
and comprises skin care, self-MLD, use of a compression
stocking, and exercises [12,13].
Although it is effective, CDT is criticized for being
time-consuming, costly, and insufficiently researched [14].
It requires trained health professionals, can be difficult
for the patient to access, and is expensive as it is provided
in an outpatient setting, but early intervention and good
self-management can prevent progression of symptoms.
With proper compliance and thorough instruction by the
clinician, the majority of patients are able to maintain and
improve the treatment results achieved during the intensive
phase of the therapy. Healthcare professionals often teach
patients or their caregivers a simplified version of MLD
and self-bandaging [13,14]. Successful management of
lymphedema relies on patients and caregivers to play an
active role in the process.
According to our literature review, there are few
papers on the results of home-based CDT in patients with
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LEL. The aim of this study is to present the practicality
and ease of treatment modification, as well as the results
experienced by our patients.
2. Materials and methods
Medical chart reviews of 159 LEL patients who were
consecutively treated in the Department of Plastic,
Reconstructive, and Aesthetic Surgery at Bezmiâlem Vakıf
University between July 2015 and June 2017 were evaluated
retrospectively. The institutional ethics committee
approved this study, which was performed in accordance
with the ethical principles for human research as outlined
by the Declaration of Helsinki, Second Revision.
2.1. Participants
We chose patients for the treatment of modified-CDT
from amongst those who had already received CDT but
failed due to financial reasons or transportation, and those
who previously had unsatisfactory results from CDT and
wanted to try self-management.
Thirty-one patients had bilateral LEL, 3 patients had
genital lymphedema, and 30 patients were recommended
only compression garments. Ninety-five patients were
found to have LEL. The inclusion criteria were as follows:
the patient must be older than 18 years of age, must have
suffered from primary or secondary unilateral lower
extremity lymphedema, and must have previously received
CDT treatment. The exclusion criteria were: having a
metastatic disease; having a previous diagnosis of coronary
heart disease, pulmonary disease, or an acute infection for
any reason; lower extremity peripheral arterial occlusive
diseases; or peripheral neuropathy. The clinical stages of
lymphedema for our cases were classified based on the
International Society of Lymphology [6]. Body mass index
(BMI) was calculated by dividing weight in kilograms by
the square of height in meters. BMIs of between 18.5 and
24.9, between 25 and 29.9, and higher than 30 were defined
as normal weight, overweight, and obese, respectively.
2.2. Measurements
The circumferences of the extremities were measured
when the patients were placed in a long sitting position,
with the ankle in the neutral position, from the first
metatarsophalangeal joint to the proximal with 4-cm
intervals for each. The values that were obtained were
recorded in centimeters and converted to extremity
volume using Kuhnke’s disc method. The circumference
measurements were repeated before and after treatment in
all patients [15].
The therapeutic response of modified CDT was
quantified as the change in the percentage of excess
extremity volume (EEV) using the following formula:
EEV (%) = (pretreatment volume – posttreatment volume/
posttreatment volume) × 100.

2.3. Treatment method
The patients at our outpatient clinic received a basic
introduction to skin care and risk reduction training.
Modified CDT consisted of self-MLD, self-bandaging, and
decongestive exercises training. The patients were clinically
followed once a week for 4 weeks under the supervision of
a trained physiotherapist.
The first session started with one-on-one teaching
with detailed explanation of the theory and principals of
an effective therapy program. A trained physiotherapist
demonstrated the self-MLD technique while the caregiver
videotaped it. In self-MLD, to stimulate lymph drainage,
the patient performed simple MLD techniques at least
once a day for 10–15 min. Stationary circles were used, and
the patients executed this technique using light pressure.
In the second step, the physiotherapist demonstrated
the self-bandaging technique in a sequence of steps,
using a diagram to aid comprehension. The caregiver
was allowed to apply this technique immediately in this
session, and it was videotaped while it was being applied
by the physiotherapist. The patients were trained on the
warning signs and symptoms of inappropriate application
of bandages, including pain, discomfort, tingling, or
numbness of fingers. They were advised to remove the
bandages completely and reapply. If symptoms and signs
persisted, they were asked to skip bandages and apply
other methods of treatment until the next week’s hospital
visit. Short stretch bandages have limited extensibility
under tension (50%). Multilayer, multicomponent, and
short stretch bandages consisted of a cotton padding layer,
a short stretch cohesive bandage (Mollelast Haft), and a
short stretch nonadhesive bandage (Rosidal K) on the top
(Lohmann & Rauscher, Rengsdorf, Germany). The three
components were applied in a spiral style, with 50% of
overlap between the layers, from the base of the toes up
to 2 cm below the hip. Mollelast Haft and Rosidal K were
applied under full stretch to exert a strong-to-very strong
pressure according to the International Compression Club’s
classification of compression materials. The participants
were told to keep the bandages 7 days a week for 16 h a
day on average. The bandages were removed while taking
a shower and at night, and then reapplied in the morning.
When they felt discomfort, they were asked to remove the
bandages and to note this in their logbooks.
For decongestive exercises, breathing exercises, gluteal
sets, knee sets, and toe flexion-extension exercises were
performed for 10–15 min following the self-bandaging
session. The exercises were performed while lying in a
supine position. The patients would rest with the extremity
elevated for 10–15 min after the exercises. The exercises
were shown to the patients individually during this session
and booklets with visual and written instructions were
distributed.
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For skin care, appropriate skin moisturizers should be
applied twice a day to maintain the health and integrity of
the skin. The patients were informed about skin care and
protection of the integrity of the skin. A booklet containing
information about what should not be done and potential
situations the patients should protect themselves from was
distributed.
The patients, who visited the outpatient clinic every
week for 4 weeks, were assessed weekly for extremity
volume measurements. The videotape was reviewed when
the patient returned to the clinic, and recommendations
for corrections in self-treatment were made based on the
video content.
2.4. Statistical analysis
Statistical analysis was performed using SPSS 21.0 for
Windows (IBM Corp., Armonk, NY, USA). Kruskal–Wallis
analysis of variance (post hoc Tukey HSD test) was used to

evaluate the differences in the changes between the stages
of LEL in all parameters. The nonparametric Wilcoxon
matched pairs test was used for intragroup comparison
of the results before and after treatment. The Mann–
Whitney U test was applied to determine the relationship
between the reduction in EEV percentage and BMI, age,
and duration of lymphedema. The Tamhane T2 test was
used to determine the 3 groups’ mean differences of EEV%
because of the groups’ unequal variance and sample size.
Statistical significance was accepted at P < 0.05.
3. Results
The study included 95 patients aged 55.84 ± 15.70 years;
34 (35.79%) were female and 61 were male (64.21%).
The mean body mass index was 31.21 ± 7.36 kg/m2. The
demographic characteristics of the patients are shown
in Table 1. The distribution of the patients based on the

Table 1. Characteristics of the patients’ lower extremity lymphedema.
N

%

Age (years)
18–30
31–50
51–65
Over 65

7
29
32
27

7.37
30.53
33.68
28.42

Sex
Female
Male

34
61

35.79
64.21

Body mass index (kg/m2) (mean ± SD)

31.21 ± 7.36

Dominant extremity
Left
Right

11
84

11.58
88.42

Diagnosis
Primary lymphedema
Secondary lymphedema

24
71

25.26
74.74

Etiologies of secondary LEL
Phlebolymphedema
Lipolymphedema
Melanoma
Postinfectious
Gynecologic cancers

28
12
15
5
11

29.47
12.63
15.79
5.26
11.58

Affected extremity
Left
Right

40
55

42.11
57.89

Lymphedema severity
Stage 1 (mild)
Stage 2 (moderate)
Stage 3 (severe)

31
48
16

32.63
50.53
16.84

Duration of lymphedema (months) (min–max)

36 (1–600)

LEL = Lower extremity lymphedema.
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affected extremity was as follows: 40 (42.11%) left extremity,
55 (57.89%) right extremity. The patients were diagnosed as
having either primary (n = 24, 25.26%) or secondary (n =
71, 74.74%) LEL. The lymphedema severity in the patients
was evaluated and classified as stage 1 (mild) (32.63%),
stage 2 (moderate) (50.53%), or stage 3 (severe) (16.84%).
The mean duration of lymphedema was 36 months (range:
1–600). The beginning of lymphedema was 0–6 months ago
for 15 patients (15.79%), 7–12 months ago for 10 (10.53%),
13–24 months ago for 14 (14.74%), 25–60 months ago for 33
(34.74%), and earlier than 60 months ago for 23 (24.71%).
Other comorbidities of the patients were also investigated.
Differences of extremity edema volume before and
after treatment were classified based on the stages of
lymphedema (Table 2). There were significant differences
before and after treatment at all stages (P < 0.001). The
mean reduction amounts of edema volume before and after
treatment were 296.05, 784.92, and 1038.50 mL for stages 1,
2, and 3 respectively. There was a correlation between stage
1 and stages 2 and 3 (r = 0.067; P < 0.001). There was no
correlation between stage 2 and stage 3 (r = 0.070; P > 0.05).
The groups were divided based on cases of primary and
secondary lymphedema to compare BMI, age, lymphedema
duration, and EEV percentage (Table 3). There was a
statistically significant difference only for EEV percentage (P
= 0.40). The EEV percentages of the secondary LEL patients
were higher than those of the primary LEL patients. The
correlation results between BMI and treatment response in

terms of EEV percentage (r = –0.99; P = 0.36) are shown in
Table 4.
4. Discussion
LEL is a chronic debilitating disease that requires lifelong management. Today, the gold standard of treatment
for lymphedema is CDT [6]. The aim of this study was
to determine the effects of home-based modified CDT
on LEL. Our results revealed that home-based modified
CDT had positive effects on volume reduction in patients
at all stages of LEL. The EEV percentage in patients with
secondary lymphedema was higher than that in the primary
lymphedema patients.
In the literature, several studies highlighted the
distinct lack of evidence for the optimal management
of lymphedema [16]. Although effective, clinically
administered CDT is criticized as being time-consuming,
costly, and insufficiently researched [17], failure to continue
treatment may result in an increase in swelling, infections,
and pain and have a negative effect on the patient’s selfimage. Supporting patient self-management is a key
component of effective chronic illness care and improved
patient outcome [18]. The patient’s involvement in their
own treatment is a part of self-management programs.
Clark et al. [19] suggested that individuals also have to cope
with the psychosocial problems generated by their chronic
disease and must manage their daily lives based on their
financial and social statuses.

Table 2. Comparison of pre- and posttreatment extremity volumes based on stages.
V0*
Mean ± SD

V1**
Mean ± SD

V0-V1***
Mean ± SD

P

Stage 1 (mL)

5510.88 ± 2308.41

5214.83 ± 2200.40

296.05 ± 232.88

0.001

Stage 2 (mL)

6853.50 ± 2522.73

6068 ± 1820.90

784.92 ± 868.24

0.001

Stage 3 (mL)

7736.60 ± 2985.23

6698.10 ± 2772.16

1038.50 ± 553.06

0.001

* Initial extremity volume.
** Posttreatment extremity volume.
*** Difference between initial and posttreatment extremity volumes.
Table 3. Comparison of primary and secondary lower extremity lymphedema
in terms of age, BMI, and EEV percentage.
Primary
Mean (min–max)

Secondary
Mean (min–max)

P

Age (years)

56.5 (18–80)

56 (24–89)

0.06

BMI (kg/m )

30 (20–53)

30 (17–49)

0.07

EEV %

6 (1–22)

9 (1–28)

0.04

2

BMI = Body mass index; EEV = excess extremity volume.
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Table 4. Comparison of mean difference of EEV% among BMI groups.
BMI Groups
Normal
Overweight
Obese

Overweight

Mean difference of EEV %
Mean ± SD

P

–1.72 ± 1.53

0.60

Obese

–0.57 ± 1.52

0.97

Normal

1.72 ± 1.53

0.60

Obese

1.14 ± 1.38

0.79

Normal

0.57 ± 1.52

0.97

Overweight

–1.14 ± 1.38

0.79

BMI: Body mass index; EEV%: excess extremity volume percentage.

Previous studies of risk factors for the development of
LEL have been limited and investigated the roles of BMI
[20]. Graf et al. [21] revealed that time of improvement in
LEL decreased with the BMI of the patient, considering
that weight gain and higher BMI are risk factors for
development and increased severity of lymphedema.
According to the results of our study, as BMI increases,
there might be a threshold above which lymphatic flow
becomes impaired. Proximal transport of lymphatic fluid
from the extremity is dependent on the function of the
lymphatic vasculature and the volume of lymph produced
by the tissues. As the amount of adipose tissue increases
in the lower extremities, lymphatic vessels may become
dysfunctional, thereby reducing proximal lymphatic
flow. Besides, a higher BMI increases complication rates,
whereas a lower BMI provides a significant reduction in
overall survival and complication rates [22]. Underweight
patients (BMI < 18.5 kg/m2) with locally advanced
cervical cancer have lower overall survival rates and more
complications than normal-weight and obese patients
[23]. The results of our study showed that there was a
decrease in the percentage of EEV, but this decrease was
not statistically significant. Studies in the literature have
focused on the results of secondary LEL development
related to high BMI. Our sample included both primary
and secondary LEL patients.
Regardless of the type of volume-reduction treatment,
burdensome lifelong self-care that includes compression,
self-administered MLD, and skin care is required to
maintain volume reduction after CDT or achieve additional
volume reduction. Zhang et al. [24] compared breast cancer
patients scheduled for modified radical mastectomy who
were randomly apportioned to undergo physical exercise
only (n = 500) or self-MLD as well as exercise (n = 500)
after surgery. The results of their study indicated that selfMLD, in combination with physical exercise, is beneficial
for breast cancer patients in preventing postmastectomy
scar formation, upper limb lymphedema, and shoulder
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joint dysfunction. Bernhard et al. [25] compared the effects
of complex decongestive physiotherapy carried out either
by a physiotherapist or by patients themselves under the
supervision of the physiotherapist. Forty-six patients were
treated and followed for 9 months. Significant reductions
were recorded after 3, 6, and 9 months of performing
comprehensive self-treatment including compression
therapy (n = 33 legs). The patients in this study consisted
only of lymphatic filariasis patients. Although our treatment
results obtained higher EEV percentages in secondary LEL
patients, they also showed that treatment was effective in
primary LEL patients. Another study assessed the quality
of life in participants performing self-lymphatic drainage
with or without aromatherapy, and both groups reported
significant improvements at all time points up to 6 months
[26]. Assigning more responsibility to patients in handling
lymph drainage and bandaging resulted in a reduction in
leg volume. Following initial treatment, adherence to the
program and follow-up were limited by the impracticality
of compressive stockings and their tendency to deteriorate
rapidly due to harsh environments. Our sample consisted
of patients who had started treatment before but could not
continue due to reasons of health insurance, transportation,
or financial resources. All patients had previously received
CDT including MLD and compression bandages. The
maintenance phase was unfinished as some of the patients
could not use the compression stockings proposed in the
maintenance phase. The fact that they were contributing
to their own treatments with the modified CDT method at
home may have caused them to feel good about themselves.
None of them left their treatment or follow-up procedures.
In a previous study, a case series about self-bandaging,
30 upper and lower extremity lymphedema patients
received a self-bandaging training program during 3–12
weeks of treatment [27]. Among all participants with
LEL, edema reduction after intensive self-bandaging
showed statistically significant differences at all stages.
In our results, there were no statistically significant
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differences between mild and severe lymphedema.
Sherman and Koelmeyer [28] showed a link between
perceived self-regulation, self-efficacy, and lymphedema
risk reduction behaviors. Success of self-bandaging in
reducing the amount of edema may bring an increased
sense of independence and a resulting feeling of being in
control of the situation. The self-bandaging program had
to be monitored by professionals, and corrections were
made in the technique or administration performed by
the patient or their caregiver(s). In our study, patients
recorded a video of both self-MLD and self-bandaging.
We used this method to overcome treatment barriers like
transportation problems, coordinating appointment times
with the patient, and the patients’ mobility problems.
The video review/correction method helps provide an
educational component to home-based self-management
of LEL. In a study that used a tele-rehabilitation program,
including sharing educational videos with LEL patients, a
viable method was found to eliminate potential physical
treatment barriers [29].

There are several limitations of this study. The results
of this study reflected only 4 weeks of modified CDT
implementation. Because of the lack of long-term followup evaluations, we could not comment on protection of
benefits. Thus, only the volume reduction rates of the
patients were provided, and whether or not actual physical
improvements of the limb(s) occurred is unknown. There
was only one intervention group. Despite the limitations,
the study obtained valuable information for further
studies.
In conclusion, we retrospectively reviewed the results
of home-based modified CDT treatments. The findings of
our study revealed the effects of home-based modified CDT
on patients who had received treatment before but failed
in the maintenance phase. This topic should be examined
by randomized controlled studies in large samples, and
the procedure’s safety should be determined and applied.
Our results revealed that home-based modified CDT is
more effective in reducing extremity edema volume in
secondary LEL than primary LEL. It should be an available
method for self-management of LEL at all stages.
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